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Chlamydia trachomatis (C. trachomatis) is the most prevalent sexually 
transmitted bacteria with devastating reproductive consequences that lead to tubal factor 
infertility (TFI).  Recent studies have implicated apoptosis – associated speck – like 
protein containing a caspase recruitment domain (ASC) as an adaptor of inflammasomes 
that stimulate IL – 1β and IL – 18 secretion, pro – inflammatory cytokines with critical 
functions in host defense against a variety of pathogens. Therefore, for the first time, we 
are reporting the use of ASC-/- mice in a mouse model of Chlamydia infection that might 
provide some information on the role of inflammasomes in the pathogenesis of 
Chlamydia infection. In this study, wild type (WT) and ASC-/- mice were infected 
with Chlamydia.  Infectivity, pathology of the upper genital tract (UGT), and, fertility 
were evaluated. In addition, expression of ASC – dependent inflammasomes and the 
activation of immune cells within the genital tract (GT) were studied.  Results showed 
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that Chlamydia infectivity in ASC-/- mice was significantly higher (p<0.05) compared to 
WT mice.  There was an observed increase in infertility within ASC-/- mice which, when 
compared to infected WT mice, was exhibited by decrease in average number of pups 
and percent pregnancy.  There was also severe UGT damage in ASC-/- mice compared to 
WT mice, correlating with the higher number of hydrosalpinx observed on the UGT 
of Chlamydia infected ASC-/- mice.  Furthermore, IL – 1β and IL – 18 production as well 
as immune cell activation were down regulated in the GT of Chlamydia infected ASC-/- 
mice.  This finding indicates that in absence of ASC, host innate and adaptive immunity 
is impaired.  Results imply that ASC plays a protective role in the mucosal immunity 
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 Chlamydia trachomatis (C. trachomatis) is the most frequently reported sexually 
transmitted bacterial infection within the United States.  In 2014 there were over 1.44 
million reported cases, a 2.8% increase from the previous year, however, it is estimated 
that well over 2.86 million infections occur annually (1).  The discrepancy between the 
reported and the estimated statistics lies with the asymptomatic nature of the pathogen.  
Most infected do not seek treatment because their bodies are not sick.  Most notably is 
the fact that Chlamydia infections are most prevalent among young people, with 1 in 15 
sexually active females within 14–19 year age group (Figure 1) (1).  Interestingly though, 
Chlamydia diagnosis rates have gradually increased over the years.  From 2006–2010 
diagnoses were up 27%; plus, screening rates have more than doubled since 2000 (1).  
Despite the rise in awareness of screening and treatments, chlamydia still remains a 
health concern that disproportionately affect African Americans nine times higher than 
whites and three times higher than Hispanics (Figure 2).  More specifically, the 
population of young black women are hit the hardest; 7,719.1 per 100,000, which likely 
reflects a combination of factors including biological differences that place females at 






rates among young women (1).  Notably, one of the leading global causes of tubal factor 
infertility (TFI) is thought to be asymptomatic infection (up to 70%) of the female 
reproductive tract with C. trachomatis (2).  Taken  together, these statistics highlight the 
impact of reoccurring infections on the upper genital tract (UGT), beginning from such 
an early age. 
 
Figure 1: Most reported Chlamydia Infections Occur among 15–24–Year–Olds (1).  Surveillance data 
shows both the numbers and rates of reported cases of chlamydia continues to be highest among 










Figure 2: Chlamydia – Rates by Race/Ethnicity, US, 2010–2014 Cdc.gov (1).  During 2010–2014, 43 
states submitted chlamydia case report data in the race and ethnicity categories.   During 2013–2014, 
rates increased among whites (2.1%) and Asians (5.2%), and decreased 2.4% among American 
Indians/Alaska Natives.  Rates were stable among blacks, Hispanics, Native Hawaiians/Other Pacific 
Islanders during 2013–2014.  *AI/AN = American Indians/Alaska Natives; NHOPI = Native 
Hawaiians/Other Pacific Islanders. 
 
1.1 Life Cycle 
Chlamydia is an obligate intercellular Gram–negative bacterium that infects both 
humans and animal species, including birds, pigs, and, cats.  Originally characterized as 
protozoan, as research progressed, their classification changed various times, and, by late 
1960s the pathogen came to be recognized as a bacterium (3-5).  The pathogen resides 
within an intracellular vacuole, which has been identified as an inclusion body, and is 
vital to the survival of the bacteria during replication (6).  The development cycle of 
Chlamydia is biphasic, adding to its unique ability to differentiate between an infectious 
and replicative stage (Figure 4).  The infectious particles, also known as elementary 





only about 0.3µm, the EBs contain condensed DNA and are responsible for infecting new 
cells to continue the replicative cycle.  Entry of the EB into the mucosal epithelial cell is 
facilitated by a type III secretion system, which releases effector proteins to aid in 
infection as well as in the ability of the bacteria to evade the host’s immune system (7).  
Upon entry, the EB transforms into its metabolically active replicative form, the reticulate 
body (RB), and increases its inclusion body size (to approximately 1µm) to accommodate 
the multiplying RBs (7).  Within 48h post infection, the RBs differentiate back into EBs 
and by 72h post infection EBs are released through either cell lysis or exocytosis (7).  
Throughout the developmental cycle, Chlamydia is continually modifying its inclusion 
membrane to avoid an endocytic pathway via the effector proteins secreted early in 
infection (7).  Interestingly, persistent infections occur when the RBs are prevented from 
EB differentiation, which results in aberrant nucleated RBs.  This has been shown to be 
triggered through antibiotic usage, limitations on available nutrients, and, the presence of 
cytokines (7).  Persistence of Chlamydia infections result in continued damaged to host 











Figure 3: The life cycle of genital serovars of C. trachomatis. The chlamydial growth cycle involves 
transformation between distinct forms: the elementary body (EB) and the reticulate body (RB). The 
highly infectious EB attaches to nonciliated columnar or cuboidal epithelial cells and induces 
ingestion by the host cell. EB are metabolically inactive and represent the extracellular C. 
trachomatis growth form. Once ingested into a phagosome, fusion of the phagosome with the host 
lysosome is prevented, a highly unusual occurrence that ensures EB survival. The EB reorganizes 
within the phagosome into a metabolically active RB. RBs are noninfectious but can replicate and do 
so by binary fission. The RB reorganizes back into EB, which will be released from the host cell to 




C. trachomatis can be classified into three distinctive serovars: A–C, D–K, and, 
L1–L3.  The ocular disease, trachoma, is caused by serovars A–C, both neonatal 
pneumonia and conjunctivitis are caused by serovars D–K, and, the systemic disease 
lymphogranuloma venereum (LGV) is caused by serovars L1–L3.  Of most importance 
are serovars D–K due to the fact that this group is associated with STIs, and when left 
untreated, results in urethritis, ectopic pregnancy, pelvic inflammatory disease (PID), 





only continual damage to the host tissues, but results in infertility.  This Chlamydia 
persistence is localized to the female UGT, specifically the fallopian tubes (9).  The 
pathology following infection of non-immune cells results in the production of pro-
inflammatory cytokines (Interleukin (IL)–1, TNF–α, etc.) and chemokines (IL–8, etc.).  
This in turns leads to the recruitment and activation of both innate and adaptive immunity 
in an effort to resolve the infection (8).  Studies have shown that both protective 
immunity and eradication are dependent upon cell-mediated immunity, leading to the 
newly adopted immunological paradigm for chlamydial pathogenesis based upon T–cell 
responses that are essential to host defense but may also lead to collateral tissue damage 
(8). 
 







  The cytotoxic effects of Chlamydia on the UGT begin with identification of EBs, 
also referred to as pathogen associated molecular patterns (PAMPs).  Since the EB is 
internalized, the pattern recognition receptor (PRR) that recognizes the pathogen has 
been observed to be the cytosolic NOD–like receptors (NLRs) (9).  The NLRs are a 
large family of intracellular proteins observed to be involved primarily in the 
activation of innate immunity in response to microbial pathogens.  Recently 
Chlamydia has been observed to yield an increase in the expression of the NLR–Pyrin 
domain containing Protein 3 (NLRP3) inflammasome activation.  Inflammasomes are 
large cytosolic protein complexes in which pro–inflammatory caspases undergo 
autocatalytic activation in response to infectious and noxious insults (10).  
Inflammasomes are also responsible for the inflammatory process activation and 
linked to pyroptosis, which is a form of programmed cell death associated with 
antimicrobial responses, acting as a defense mechanism against infection by inducing 
inflammation (11).  The formation of an inflammasome and the activity of caspase-1 
(CASP–1) determine the balance between pathogen resolution and disease pathology.  





its activation relies on two factors: (1) nuclear factor kappa–light–chain–enhancer of 
activated B cells (NF-κB)–dependent transcriptional induction downstream of NOD 
ligands or inflammatory cytokines and (2) an agonist to induce oligomerization (12).  The 
formation of the NLRP3 inflammasome begins once these factors are present and 
involves the assembly of platform proteins (NLRP3), effector proteins (CASP–1), and, 
adaptor proteins (apoptosis–associated speck–like protein containing a caspase 
recruitment domain (ASC)) (Figure 3).  The NLRP3 contains a nucleotide-binding 
domain–leucine-rich repeat (NBD-LRR), while the monomeric CASP–1 contains the 
caspase domain required for the processing of pro – IL-1β and pro–IL–18 (Figure 5). 
 
 
Figure 5: Domain architecture of NLRP3 Inflammasome.  NLRs are characterized by the combined 
presence of a NACHT domain followed by a variable number of LRRs.  The PYD domain of NLRP3 






2.1 ASC Adaptor Protein 
Originally named for its ability to induce apoptosis when over expressed in HL–
60 human leukemia cells, ASC is now considered a key mediator in apoptosis and 
inflammation (13).  The ASC mRNA gene is encoded by three exons: 1) PYRIN–PAAD–
DAPIN (PYD) domain 1–90 amino acids long, 2) proline and glycine–rich (PGR) 
domain, and, 3) caspase–recruitment (CARD) domain 107–195 amino acids long (16).  
The PYD and CARD domains are members of the six – helix bundle death domain–fold 
superfamily that mediates assembly of large signaling complexes within the 
inflammatory (innate immunity) and apoptotic signaling pathways, both through the 
activation of caspase-8 (17).  Of special note, two transcript variants encoding different 
isoforms have been identified, and ASC is one of the few proteins in the human genome 
that contains both an N–Terminal and a C–Terminal CARD, which allow it to bridge 
PYD–containing proteins with the CARD of caspase–1 (18).  The location of the protein 
is primarily in the nucleus of resting monocytes and macrophages, but ASC rapidly 
redistributes to the cytoplasm upon pathogen infection (16).  The ASC protein is widely 
expressed at low levels in various organs and peripheral blood leukocytes, however, very 
low levels are detected within the heart, brain, and, skeletal muscle (18). 
Interestingly, proteins containing the death domain fold motifs control the delicate 
balance between survival and death through regulation of NF–κB and caspase activity 
(18).  The ASC protein promotes caspase – mediated apoptosis predominantly involving 





mentioned, the innate immunity response acts as an integral adapter in the NLRP3 
inflammasome, which leads to the activation of caspase–1 and the processing 
andsecretions of downstream pro – inflammatory cytokines IL–β and IL–18 (19).  The 
ASC protein has been observed facilitating the translocation of Bax to the mitochondria, 
inadvertently mediating the p53–Bax mitochondrial apoptotic pathway, thusly 
implicating itself in both tumor suppression and apoptosis (19, 21).  Within the research, 
ASC is also known as Target of Methylation-mediated Silencing (TMS1) due to the 
suppression of its expression in human tumors via methylation of CpG islands within the 
gene (10, 19).  More recently, ASC knockout studies have suggested a role for ASC in 
adaptive immunity that is independent of the NLRP3 inflammasome (20).





PUBLIC HEALTH CONCERN 
 
3.1 Infertility  
Fertility in women is overwhelming affected by unresolved or untreated infection 
of the reproductive tract with C. trachomatis (2).  Consequences of prolonged exposure 
to the pathogen are observed within its target areas, which include the fallopian tubes, 
oviduct, and, ovaries–all components of the UGT and required for effective reproduction.  
The UGT plays an essential role in reproduction by way of gamete and zygote 
transportation.  Specifically, gamete transport relies on ciliary activity, fallopian tube 
contractions, and, tubal secretions (2).  Failures of these transport mechanisms, which can 
arise from chlamydial infections, are direct consequences of luminal architecture 
distortions (2).  Studies have revealed that chlamydial infections of the UGT produce a 
mixture of patches of flattened cells along with loss of cilia or single elongated–cilium 
cells (2).  It should be noted that women with TFI are defined as having either damaged 
or occluded fallopian tubes or a history of salpingectomy (2).  Such tubal diseases 
resulting in TFI are generally due to the inflammatory process occurring either in or 
around the fallopian tube.  In the case of Chlamydia, disease severity can range from 





severity and duration of the infection (2).  Interestingly, the severity of the inflammatory 
response towards the infection is enhanced during re–infections and results in the known 
pathologies of inflammation, tissue damage, and, scarring. 
Collectively, studies have shown that when recurrent chlamydial infections are 
left untreated, the results are traumatic tissue damage and a decrease in the ability to 
reproduce.  These known C. trachomatis structural changes within the UGT are a result 
of the activation of the innate and adaptive immunity, which is a requirement to clear the 
infection.   A better understanding of the activation of the immune system would 
highlight possible innate immunoregulators.  It should be noted that ASC has previously 
been suggested as an important molecular component of innate immunity activated 
specifically by chlamydial and other parasitic infections (9, 21).  
 
3.2 Significance 
Chlamydia trachomatis (C. trachomatis) is a public health concern due to its 
prevalence and devastating reproductive consequences within developed and developing 
countries (7).  As of 2014, 51,945 cases were reported in Georgia, with 6,575 of the 
state’s reported cases coming from Fulton County, which includes the city of Atlanta.  
Within the US, the rates of reported cases were most prevalent within the 15–24 year old 
female age group, while the male age group was 20–24 year old within the population 
(1).  Known as the silent infection, the STI can persist within a host and results in 





female UGT, where in chronic infections chlamydiae have ascended and are known to 
cause pelvic inflammatory disease (PID), chronic pelvic pain, tubal factor infertility  
(TFI), and, ectopic pregnancy (8).  The host relies on the adaptive immunity to begin the 
clearance of the infection; however the host response to the pathogen requires the 
initiation of the inflammatory process.  And due to recurrent infections, the ending result 
is severe tissue damage, which leads to infertility, otherwise known as TFI.  Recently, the 
NOD–like Receptor – Pryin domain containing 3 (NLRP3) Inflammasome has been 
identified as the inducer of the inflammatory process during C. trachomatis infections.  
And more importantly, its adapter protein ASC has emerged as a key mediator in both 
apoptosis and inflammation.  Studies have implicated ASC as an important component of 
the innate immune system, specifically, citing the direct dependency of innate immunity 
for ASC following Chlamydia infections of the oviduct (9).  Therefore, we hypothesize 
that the immunoregulatory effects of ASC affect the mucosal and systemic immunity 







The research presented within the current dissertation is concentrated on acquiring 
a better understanding of the association between ASC and C. trachomatis on both the 
mucosal and systemic aspects of immunity following infection. 
 
Specific Aim 1: To investigate a potential link between NLRP3 inflammasome 
adapter protein ASC and Chlamydia–induced infertility following infection. 
It has previously been reported that a single chlamydial infection of the UGT does 
not result in tubal scarring; however, prolonged exposure to Chlamydia due to a chronic 
persistent infection or frequent reinfection has been associated with chronic inflammation 
associated with TFI (2).  Inflammasome activation produces the essential pro–
inflammatory cytokines, which in turn recruit an influx of immune cells necessary to 
begin the clearance of C. trachomatis.  Therefore, we propose to examine the association 
between ASC and C. trachomatis on A) Infectivity and B) Fertility following recurrent 
infection. 






Successful fertility relies on intact, functioning, and, secreting cells within the 
UGT.  As a consequence of recurrent infections, C. trachomatis histopathology results in 
the influx of immune cells to the site of infection for clearance, and ciliated cells become 
damaged and tissue is scarred (2, 9).  Hence, the cells can no longer transport the gamete 
through the UGT (9).  Therefore, we propose to investigate the immunoregulatory effects 
of ASC on the known A) Histology and B) Pathology of C. trachomatis infected UGT 
post infection. 
 
Specific Aim 3: To analyze the regulatory effects of ASC on the maturation of DCs 
following Chlamydia stimulation. 
The inflammasome is important in activating the innate immunity and the ensuing 
adaptive immunity response (9).  Signaling for these downstream effects relies on the 
capability of antigen–presenting cells (APCs) to function properly and in rapid 
succession for clearance.  Dendritic Cells (DCs) are important when it comes to antigen 
presentation; they are the link between the innate and adaptive immune systems post C. 
trachomatis infection.  Therefore, we propose to investigate the immunoregulatory role 
of ASC on A) The maturation of DCs and B) The DCs antigen–presenting function of 





METHODS AND MATERIALS 
 
5.1 Mice. 
Six week old female wild type (WT) mice with C57BL/6 J background were 
purchased from The Jackson Laboratory, and female ASC-/- mice were provided by Dr. 
Dixit at Genentech.  Mice were fed food and provided water ad libitum, and maintained 
in laminar-flow racks under pathogen-free conditions with a 12-hr light and a 12-hr dark 
cycle in an accredited animal facility at Morehouse School of Medicine. The protocols 
involving mice were performed in compliance with Morehouse School of Medicine-
Institutional Animal Care and Use Committee (MSM-IACUC) and prescribed federal 
guidelines. 
5.2 Chlamydia Stocks. 
 Stocks of Chlamydia muridarum (C. muridarum), the agent of mouse 
pneumonitis, (Division of Scientific Research, Centers for Disease Control and 
Prevention) used for infections were prepared by propagating elementary bodies (EBs) 
in McCoy or HeLa cells (Division of Scientific Research, Centers for Disease Control 
and Prevention), according to standard procedures.  The cell lines were maintained in 
Minimum Essential Medium (MEM) supplemented with Earle’s with 2mM L-glutamine, 
10% heat-inactivated FBS, 1mM sodium pyruvate, 0.5% fungizone, and, 1.0%  
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penicillin/streptomycin (100U/mL; 100µg/mL) in a humidified atmosphere under 5% 
CO2, at 37°C.  Chlamydial stock titers were expressed as inclusion forming units (IFU) 
per milliliter. 
5.3 Bone Marrow DC (BMDC) Extraction. 
Immature DCs were isolated from the bone marrow of WT and ASC-/- mice (n = 5 
per group) by the standard method and differentiated in vitro by culturing with IL–4 and 
granulocyte-macrophage colony-stimulating factor (GM-CSF), as described by Inaba. 
(28).  Briefly, bone marrow progenitor cells from mice femurs were removed, washed 
three times with RPMI 1640 supplemented with 10% FBS, and, incubated in RPMI1640 
supplemented with 10% fetal bovine serum (FBS), 10 mM HEPES, 200 mM glutamine, 
100 mM sodium pyruvate, 0.5% HEPES, 5ng/mL IL–4, and, 10ng/mL GM–CSF at 37C 
for 6 days, replacing with fresh media on day 3 and transferring cells to new dishes on 
day 5.  After 5 days in culture, the cells were characterized as loosely adherent 
mononuclear cells and further purified as CD11c expressing DCs by using the Pan 
Dendritic Cell Isolation Kit from Miltenyi Biotec. 
5.4 Infectivity. 
The WT and ASC-/- mice (n = 8 per group) were anesthetized with sodium 
pentobarbital (30µg/body weight) (Sigma-Aldrich) and infected intravaginally with 20µl 
of 1 X 105 IFUs of C. muriduram approximately 5 days after intramuscular dministration 
of 2.5 microgram/mouse Depo Provera (Pfizer Inc.).  Infections were administered three 
times, four weeks apart.  After the initial infection, the mice were swabbed vaginally 
every three days for two weeks and once a week for two weeks.  The course of infection
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was monitored by isolation of Chlamydia from the collected cervicovaginal swabs 
cultured in 24–well plates with McCoy cells (Division of Scientific Research, Centers for 
Disease Control and Prevention) at 37°C, 5% CO2 for 1hr.  Culture media was replaced 
with MEM media supplemented with 2mM L-glutamine, 10% heat-inactivated FBS, 1 
mM sodium pyruvate, and, 0.5% fungizone and incubated at 37°C, 5 %CO2 for an 
additional 48hrs.  The Pathfinder, Chlamydia Culture Confirmation System (Bio-Rad) 
manufacture’s protocol was followed for immunofluorescence staining and IFU counting. 
5.5 Fertility Assay. 
 Two weeks post the 3rd infection infected and uninfected WT and ASC-/- mice (n 
= 8 per grpup) were transferred to cages with a male mouse of the same strain and 
maintained as previously stated.  Each cage contained no more than two female mice per 
group for mating purposes.  The mice were checked twice weekly for weight gain as a 
sign of fertility.  Fifteen days post mating, female mice from both experimental groups 
were euthanized, and the number of pregnant mice and the mean number of pups in the 
different groups were enumerated and calculated. 
5.6 Histopathology. 
5.6.1 Assessment of Chlamydia Induced Infertility. 
The UGTs of uninfected and infected infertile WT and ASC-/- mice (n = 4 per 
group) from the fertility assay were harvested fifteen days post mating and observed 
grossly for the presence of Chlamydia induced pathologies, including hydrosalpinx and 
uterine abnormalities.  Following examination, the UGTs were placed flat on cardboard 





temperature, and then stored at 4°C. 
5.6.2 Assessment of Persistent Chlamydia Induced Inflammation. 
Two weeks post the 3rd infection the UGTs of non–mated uninfected and infected 
WT and ASC-/- mice were harvested and fixed in 4% buffered formalin and embedded in 
paraffin.  Briefly, formalin fixed tissues were washed in 1X PBS for 10min and 
dehydrated with increasing ethyl alcohol (Thermo Fisher Scientific Inc.) concentrations 
for 2hrs each at room temperature.  Tissues were then treated with an ethyl 
alcohol/xylene mixture beginning with a 3:1 and ending with 1:3 for 2hrs each at room 
temperature followed by and overnight incubation in pure xylene (VWR) at room 
temperature.  After 2 days of 3hr pure xylene incubations, tissues were transferred to 
disposable molds with pure xylene, incubated 56–58°C three times for 3hrs, and, left 
incubating overnight.  On day three pure xylene was replaced with precision cut paraffin 
wax (Thermo Fisher Scientific, Inc.) and blocks were left on the chiller overnight.  
Solidified wax blocks were then stored at room temperature.  Longitudinal sections 
measuring 4µm were cut, processed, and, stained with either hematoxylin and eosin or 
Masson's trichrome (Thermo Fisher Scientific Inc.) according to the manufacturer’s 
protocol.  Evaluations of the stained sections were blinded and each anatomic site (ovary, 
oviduct, and, uterine horn) analyzed for the presence of inflammation, edema, immune 
cells, fibrosis, stromal vacuoles, ectasia, and, apoptotic necrosis. 
5.7 Immunofluorescence Microscopy.  
Two weeks post the 3rd infection the UGTs of non–mated uninfected and infected 




and embedded in paraffin.  Longitudinal sections measuring 4µm were cut and 
deparaffinized.  Tissue slides were blocked with normal goat serum and labeled with 
primary (Santa Cruz) and fluorescent–conjugated secondary antibodies (Jackson 
ImmunoResearch Labs) specific for DCs, CD4+ T–cells, and, Macrophages, while the 
DNA was stained with DRAQ5 (Abcam), and, mounted in Fluorogel with Tris Buffer 
(Electron Microscopy Sciences).  Images were observed separately from different fields 
within the ovary, oviduct, and, uterine horn with the Carl Zeiss 510 Vis confocal 
microscope.  The total number of positively stained immune cells were counted and 
graphed.  Statistical significance was judged at p<0.05 using a Student t–test and 
ANOVA. 
5.8 T – cell Co – culture. 
5.8.1 Enrichment of GT DCs. 
Whole genital tracts (GTs) from uninfected WT and ASC-/- mice (n = 10 per 
group) were harvested and pooled per group.  Single cell suspension was obtained 
through tissue digestion.  Briefly, the tissue was minced, treated with 5mg/ml collagenase 
(Atlanta Biologicals) in Hanks' balanced salt solution (Mediatech) ,and, 1mg DNAse 
(Sigma–Aldrich) in 5ml calcium/magnesium-free Hanks' (CMF) buffer (Sigma–Aldrich) 
at 37 °C for 20m.  After incubation, 1 ml of 180 mm EDTA (Boston BioProducts, 
Ashland) was added to each sample, followed by tubular rotation at room temperature for 
5m.  Single cell suspensions were prepared by expressing the digests through a 70μm 




5.8.2 Enrichment of GT T – cells. 
Whole GT from Chlamydia–infected WT and ASC-/- mice (n = 10 per group) 
were harvested and pooled per group.  Single cell suspension was obtained through time 
digestion.  Briefly, the tissue was minced, treated with 0.6mg collagenase (Atlanta 
Biologicals) in 5% FBS (HyCloneTM Fetal Bovine Serum) , and, incubated at 37 °C for 
45m.  The digest were passed through a 40μm FalcomTM Cell Strainer in CMF, 
centrifuged twice and resuspend with 1%HEPES/5%FBS (Mediatech). 
5.8.3 T – cell Proliferation. 
Dendritic cells (DCs) were isolated from the single cell suspension of uninfected 
GT from WT and ASC-/- mice per MACS Miltenyi Biotec’s Pan Dendritic Cell Isolation 
Kit protocol and ϒ–irradiated (2,000 rad, 3m 10s).  In a round bottom 96–well plate ϒ–
irradiated DCs (50µl; final concentration 1 X 105) and UV–Chlamydia (50µl; final 
concentration 25 X 105) were incubated at 37 °C for 30m.  T–cells were isolated from the 
single cell suspension of Chlamydia infected GT from WT and ASC-/- mice per MACS 
Miltenyi Biotec’s Pan T Cell Isolation Kit (mouse) protocol.  T–cells (50µl; final 
concentration 5 X 105) were added to the round bottom 96 – well plate containing ϒ– 
irradiated DCs and UV–Chlamydia (final volume of 250µl) and incubated at 37 °C for 5 
days.  T–cell proliferation was detected per Cell Signaling XTT Cell Viability Kit 
protocol. The mean and SD of all replicate cultures were calculated. 
5.9 Cytokine Profile 5.9.1 Genital Tract DC Antigen Presentation. 




were collected, pooled, and, analyzed by Bio-Plex Pro Mouse Cytokine 23-Plex 
multiplex array according to manufacturer’s guidelines (Bio-Rad). The concentration of 
cytokines in each sample was obtained by extrapolation from a standard calibration curve 
generated simultaneously. The mean and SD of all replicate cultures were calculated. The 
experiment was repeated three times. 
5.9.2 BMDC Antigen Presentation. 
Splenocytes were obtained from spleens of Chlamydia infected WT and ASC-/- 
mice using a 40µm filter and syringe plunger and resuspended in PBS. CD4+ T cells were 
then purified using the MACS mouse Pan T Cell Isolation Kit (mouse) (Miltenyi Biotec, 
Auburn, CA). To assess the antigen-presenting function of DCs from either ASC-/- or WT 
mice, 1 × 105 DCs were co-cultured with 2 × 105 purified T–cells in the presence or 
absence of UV-inactivated C. muriduram in 96-well tissue culture plates for 5 days. The 
amounts of IL-2,-5, -9, -12, -13, -17A, IFN-γ, MIP-1β, RANTES, and TNF-α in the 
culture supernatants were measured using the Bio-Plex Pro Mouse Cytokine 23-Plex 
multiplex array according to the manufacturer’s guidelines (Bio-Rad, Hercules, CA). T–
cell proliferation was detected using Cell Signaling XTT Cell Viability Kit protocol 
(Danvers, MA). The concentration of cytokine in each sample was obtained by 
extrapolation from a standard calibration curve generated simultaneously. The mean and 






5.10.1 Genital Tract DC Protein Expression. 
Two weeks post the 3rd infection, the UGTs of uninfected and infected WT and 
ASC-/- mice (n = 4 per group) were harvested and homogenized RIPA lysis buffer 
supplemented with 1mmol/L phenylmethylsulfonyl fluoride and protease inhibitor 
cocktail (Promega) using the gentle MACS Dissociator for total protein extraction per 
MACS Miltenyi Biotec protocol.  UGT protein levels, consisting of the ovary, oviduct, 
and, the upper half of the uterine horn, were equalized by PierceTM BCA Protein Assay 
Kit, loaded resolved by 4%–20% TGX gel (Bio-Rad) gradient gel, and run for 1hour.  
Proteins (40µg) were then transferred onto nitrocellulose paper (Bio-Rad).  After 1hour, 
blots were washed, blocked with 5% milk, then incubated with primary antibody for 
NLRP3, CARD12, AIM2, pro–caspase–1, IL-1β, IL–18, and, GAPDH (Santa Cruz) 
overnight at 4°C.  Horseradish peroxidase (HRP) – conjugated secondary antibodies 
(R&D Systems) were added for 1 hour at room temperature, blots were then developed 
using Clarity Western enhanced chemiluminescence (ECL) substrate (Bio-Rad) and 
viewed with ImageQuant LAS 4000 (GE Healthcare). The mean and SD of all replicate 
cultures were calculated. 
5.10.2 BMDC Protein Expression. 
Lysates from Chlamydia stimulated WT and ASC-/- BMDCs were prepared by 
homogenization in lysis buffer supplemented with 1 mmol/L phenylmethylsulfonyl 
fluoride and protease inhibitor cocktail on ice. 20µg of WT and ASC-/- DC lysates and 




Rad, Hercules, CA) and run for 1 hour. Proteins were then transferred onto nitrocellulose 
paper (Bio-Rad, Hercules, CA). After 1 hour, the blots were washed, blocked with 5% 
milk, and then incubated with primary antibody for ASC, ENO1, hexokinase, pyruvate 
dehydrogenase E1 component subunit alpha (PDHA1), triosephosphate isomerase (TIM), 
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Santa Cruz, Dallas, TX) 
overnight at 4°C. Horseradish peroxidase (HRP)-conjugated secondary antibodies (R&D 
Systems) were added for 1 hour at room temperature, and then the blots were developed 
using Clarity Western enhanced chemiluminescence (ECL) substrate (Bio-Rad, Hercules, 
CA) and viewed with ImageQuant LAS 4000 (GE Healthcare, Pittsburgh, PA). The mean 
and SD of all replicate cultures were calculated. The experiment was repeated three 
times. 
5.11 Adoptive Transfer. 
Isolated BMDCs from WT and ASC-/- mice were stimulated with C. muridarum 
EBs for 2hrs and adoptively transferred into 6-8 weeks old female WT mice (2.5 X 107 
cells/mouse) by intravenous infection into the tail vein in 0.2mL of 1X PBS (n = 4).  
Treated mice were infected intravaginally with 1×105 IFU/mouse of live C. muridarum 1 
week after adoptive transfer.  The status of the infection was monitored by periodic 
cervicovaginal swabbing of individual animal and isolation of Chlamydiae in tissue 
culture as previously described. 
5.12 Flow Cytometry and Cytokine Expression. 
Isolated BMDCs from the bone marrow of WT and ASC-/- mice (n = 5 per group) 




FACS Buffer at 4°C and stained with FITC- , PE- , or APC-conjugated antibodies against  
CD80, CD103, MHC II, CD40, CD14, TLR4, and CD11c (BD Pharmingen). Cultured 
supernatants were collected and analyzed by Bio-Plex Pro Mouse Cytokine 23-Plex 
multiplex array according to manufacturer’s guidelines (Bio-Rad, Hercules, CA). The 
concentration of cytokine in each sample was obtained by extrapolation from a standard 
calibration curve generated simultaneously. The mean and SD of all replicate cultures 
were calculated. The experiment was repeated three times. 
5.13 Pyruvate Assay. 
Isolated WT and ASC-/- BMDCs were stimulated with C. muriduram in 24-well 
tissue culture plates at a ratio of 1:5 for 1and 2hours.  The BMDC supernatants were 
collected and analyzed for pyruvate using the Eton Bioscience Pyruvate Assay Kit (San 
Diego, CA). Each sample was incubated with the Pyruvate Assay Kit Reaction Solution 
in a 96-well flat bottom reader plate for 30min at 37°C and measured at 570 nm. Included 
in the OD570 reading were unstimulated WT and ASC-/- BMDCs and culture media, both 
control groups. The concentration of pyruvate from each sample was obtained by 
extrapolation from a standard calibration curve generated simultaneously. The mean and 
SD of all replicate cultures were calculated. The experiment was repeated three times. 
5.14 Transmission Electron Microscopy (TEM). 
Isolated WT and ASC-/- BMDCs were stimulated with C. muriduram at a ratio of 
1:5 for 2hours in 24-well tissue culture plates. The BMDCs were washed and fixed on a 
glass slide with 2.5% (w/v) glutaraldehyde–0.1 M cacodylate buffer for 2–6hours at room 




Vibratome (EM Corp., Chestnut Hill, MA), and post fixed in aqueous osmium tetroxide.  
Fixed BMDC slices were dehydrated through graded ethanol and propylene oxide, and 
embedded in Polybed 812 resin (Polysciences, Inc., Warrington, PA). Thin sections (80 
nm) were then cut with a diamond knife and stained with 5% uranyl acetate and 
Reynold’s lead citrate. A JEOL 1200EX transmission electron microscope was used to 








6.1 ASC deficiency results in higher number of IFUs following an acute Chlamydia 
infection.  
We first wanted to assess a link between ASC deficiency and the initial or acute 
chlamydial infection.  This was accomplished through comparing the course of genital 
chlamydial infections between WT and ASC-/- mice (Figure 6).  Our infectivity data 
confirmed the presence of infection though the observance of chlamydial IFUs.  As with 
our lab’s previously published WT mice infectivity data (22), our current data shows a 
decreasing trend in IFUs, with the infection nearly cleared 28 Days post the initial 
infection.  Conversely, the number of chlamydial IFUs within ASC-/- mice were 
significantly higher (p<0.05) beginning on Day 15 post the initial infection, and remained 
significantly higher throughout Day 28 in comparison to the WT mice.  This heavy 
bacterial load and long duration of infection within the ASC-/- mice may in fact increase 







Figure 6: Course of genital Chlamydia infection in WT and ASC-/- mice.  Mice were infected 
intravaginally with 1×105 IFU/mouse of C. muridarum. The status of the infection was monitored by 
periodic cervicovaginal swabbing for the isolation of chlamydiae in tissue culture.  ASC-/- mice 
exhibit an increase in the average number of IFUs compared to WT.  (p<0.05) 
 
6.2 Histological Assessment of the UGT pathology and fertility in Chlamydia 
infected ASC-/- mice 
 It has previously been shown that activation of inflammasomes is required for 
Chlamydia-induced inflammatory pathology of the UGT.  We therefore assessed the role 
of ASC in inflammatory tubal pathologies and fertility in mice infected multiple times 
with C. muridarum.  Significant changes in tissue morphology were detected in the H&E 
stained ovaries, oviducts, and uterine horn sections of ASC-/- mice. Six out of 10 ASC-/- 





2 out of 10 Chlamydia infected WT mice (p<0.005) (Figure 7A). 
No visible signs of tissue damage were observed within the UGT of uninfected 
WT and ASC-/- mice.  The ovary of the infected WT mice exhibited vacuoles within the 
epithelia lining, whereas the clear vacuoles observed within the stromal cells and 
epithelia cell of infected ASC-/- mice were similar to those observed within uninfected 
ASC-/- mice.  The oviduct of the infected WT mice exhibited mild vacuoles and cellular 
degeneration, whereas moderate ectasia occurred within ASC-/- mice.  The uterine of the 
infected WT mice exhibited less cellular degeneration compared to ASC-/- mice, whereas 
necrosis, ectasia, and, edema occurred within ASC-/- mice (Figure 7B).  We also 
evaluated the UGT for fibrosis with Masson’s trichrome stain.  Analysis in Figure 7C 
shows no observed difference in the presence of fibrosis between infected ASC-/- and WT 
mice.   
Results from the fertility assay showed that non – infected WT and ASC-/- mice 
had 100% and 79% pregnancy respectively compared to infected WT mice (60%) and 
ASC-/- mice (38%) (p = 0.00008).  There was also a significantly higher number of pups 
in non–infected WT and ASC-/- mice compared to Chlamydia infected WT and ASC-/- 
















Figure 7: Chlamydia induced histopathological and fertility changes. A. WT and ASC-/- mice 
exhibiting known Chlamydia infection characteristic trait; hydrosalpinx.  The graph depicts the 
average number of mice hydrosalpinx occurrences within the multi–infected Chlamydia 
infected/infertile group. B. Histopathological data indicates no visible signs of tissue damage within 
the GT of uninfected WT and ASC-/- mice. C. Masson’s Trichrome analysis showed no difference in 
the presence of fibrosis between infected ASC-/- and WT mice GT. D. Infected ASC-/- mice exhibit an 
increased risk of infertility post Chlamydia infection. (p<0.05) 
 
6.3 ASC deficiency decreases mucosal immune cell population 






immune cells, the UGT of uninfected and infected WT and ASC-/- mice were analyzed by 
high-resolution, immunofluorescence confocal microscopy.  Figure 8A shows the 
population distribution differences for DCs, CD4+ T–cells, and, Macrophages present 
within the uninfected and Chlamydia infected WT and ASC-/- mice ovary, oviduct, and, 
uterine horn.  The difference in immune cell distribution observed between the 
Chlamydia infected WT and ASC-/- mice GTs suggest a possible explanation for the 
tissue damage previously observed within the UGT of infected ASC-/- mice (Figure 8B). 
The total population of immune cells observed within uninfected UGT of ASC-/- 
mice was similar in comparison to uninfected UGT WT mice for positively stained DCs, 
CD4+ T–cells, and, Macrophages (Figure 8B).  This similarity correlated with our 
observed pathology data (Figure 8A-B), indicating that ASC deficiency does not on its 
own trigger an increase in the number of immune cells within the female reproductive 
tract.  The population of CD4+ T–cells and Macrophages were significantly decreased 
(p<0.04 and p<0.01 respectively) within the UGT of infected ASC-/- mice when 
compared to the UGT of infected WT mice.  Interestingly, there was no significant 











Figure 8: Chlamydia infected GT from WT and ASC-/- mice labeled for DCs, CD4+ T-cells and, 
Macrophages. A. Immunofluorescence of immune cell distribution within the ovary, oviduct, and, 
uterine horn. Immune cells labeled green and nucleus labeled blue.  B. Graph depicting total cell 
count ± SD of positively stained DCs, CD4+ T–cells and, Macrophages.  ASC-/- mice exhibit a decrease 
in the presence of Dendritic cells, CD4+ T–cells, and, Macrophages post chronic Chlamydia infection 
when compared to WT mice (p<0.05) 
 
6.4 ASC regulates DC function and T – cell integrity     
The DC is the most potent APC and appears the sole cell type capable of inducing 
primary T–cell responses.  Following antigen uptake, DCs mature, costimulatory 
molecules such as CD40, CD80, and, CD86 are up-regulated, and, the DCs migrate to the 
lymphoid tissues where they activate effector T–cells (24).  To further characterize the 
effect of ASC deficiency on DC function, Chlamydia infected WT and ASC-/- mice UGT 
T–cells were co–cultured with WT or ASC-/- mice UGT DCs from infected (Figure 9).  
The ASC-/- DCs yielded a significant decrease in WT T–cell activation when compared to 





compared to WT DCs.   Interestingly, ASC-/- T–cell activation was drastically reduced 
when co–culture with WT DCs compared to the control (OD450 value 0.37 vs 2.08), 
demonstrating a loss in the integrity of T-cells.  Taken together, the findings suggest ASC 
deficiency affects the ability of DCs to optimally initiate an adequate immune response. 
Since an adaptive response is necessary for limiting the spread of the infection, 
and providing protection against recurrent infections (25), we next we analyzed the 
cytokine profiles of the WT/ASC-/- DC T–cell co-culture.  We found that IL–12, IFN–ϒ, 
and, TNF–α (Th1) cytokine production decreased, while IL–10 and IL–17A (Th2) 
cytokine production increased for ASC-/- T–cells when compared to WT T–cell cytokine 
profile.  It is important to note that in response to a Chlamydia infection, T–cells exhibit a 
characteristic Th1 response by secreting large amounts of IFN–ϒ and secretion of IL–12 
and TNF–α induces protection, all of which are required to aid in clearing the bacterial 
infection (26).  Conversely, secretion of pro–inflammatory cytokine IL–10 along with the 
IL–17A cytokine following Chlamydia infection is associated with an increase in disease 
pathology (25).  In our study, the observed decrease of Th1 and overexpression of Th2 








Figure 9: Chlamydia clearance is decreased in the absence of ASC.  A. ASC-/- mice T–cell activation 
was significantly decreased when compared to WT mice. In addition, ASC-/- mice DCs lost their 
antigen presenting function to WT T–cells when compared to WT mice (p<0.05).  B. ASC-/- mice T–
cells exhibit a change in secretion profile by decreasing IFN–ϒ, IL–12, TNF–α (Th1) and increasing 





6.5 ASC deficiency inhibits IL-1β expression 
In the absence of the ASC adaptor protein, ASC – dependent inflammasome 
assembly is expected to be abolished; therefore we want to investigate the effects on the 
individual inflammasome proteins, as well as the activation of the downstream pro–
inflammatory cytokines, specifically IL-1β (Figure 10).  We observed that the expression 
of NLRP3, CARD12, and AIM2 in the UGT of ASC-/- mice was comparable to 
expression in the UGT of WT mice, indicating that ASC–dependent inflammasome 
proteins are not affected by the absence of the adaptor protein ASC. 
As expected, the effector pro–caspase–1 protein, which is not ASC–dependent, 
was only detected in the UGT of WT and ASC-/- mice that were infected with Chlamydia.  
Pro–inflammatory cytokine IL–18 expressions remained unchanged when the UGT of 
infected WT and ASC-/- mice were compared.  Nagarajan and colleagues have identified 
that IL-1β secretion is dependent upon caspase–1 activation and ASC–dependent 
inflammasomes during Chlamydia GT infection (8).  Our current study corroborates with 
their findings in that we show the  expression of IL-1β was eliminated within the UGT of 
Chlamydia infected ASC-/- mice, and only detectable within the UGT of Chlamydia 
infected WT mice.





Figure 10: Expression of UGT ASC–dependent inflammasome proteins and pro–inflammatory 
cytokines post chronic Chlamydia infection.  Western blot analysis showed no change in ASC–
dependent inflammasome expression along with decreased IL-1β expression within the ASC-/- mice 
when compared to WT mice. 
 
6.6 Deficiency of ASC induces changes in BMDC maturation and cytokine profile 
In order to determine if the immunometabolic damage within ASC-/- BMDCs has 
an effect on DC activation, we measured the expression of activation markers and 
cytokine profile on Chlamydia stimulated WT and ASC-/- BMDCs. Figure 11A shows 
that following 2 hours of stimulation, the expression of DC activation and maturation 
surface markers CD80 (WT 24.15% vs ASC-/- 2.39%), TLR4 (WT 3.97% vs  ASC-/- 
3.12%), CD40 (WT 81.79% vs ASC-/- 0.72%), and MHC II (WT 90.42% vs ASC-/- 
9.78%) were downregulated in ASC-/- BMDCs whereas, CD 103 (WT 0.03% vs ASC-/- 
1.04%) and CD14 (WT 0.61% vs ASC-/- 41.30%) were upregulated. ASC-/- BMDCs




exhibited a different cytokine profile compared to WT BMDCs. The cytokine profile 
showed that there was a significant decrease in Th1 cytokine secretions of IL-3, -9, -12, 
GM-CSF, and IFN-ϒ; and a significant increase in the Th2 cytokines IL-5, -10 and -17A 
in ASC-/- BMDCs (Figure 11B). Interestingly, IL-β expression was doubled between 
unstimulated and stimulated ASC-/- BMDCs (13.3 vs 26.52), which might be due to an 










Figure 11: Effect of targeted inhibition of ASC deficiency on DC expression of maturation and co-
stimulatory molecules. A.  Chlamydia stimulated WT and ASC-/- BMDCs were stained with FITC-, 
APC- and PE-conjugated mAbs against the indicated surface markers and analyzed by flow 
cytometry after gating for DCs according to scatter criteria. The results are representative plots for 3 
independent experiments. Bar graph (11A) shows mean percentages and SD of markers were derived 
from those 3 experiments. B. The concentration of cytokine in each sample was obtained by 





6.7 Evidence for ASC regulation of antigen- processing events in BMDCs 
Since activated DCs produce the cytokines that initiate inflammation and help 
modify the direction of the T–cell response, we determined the effect of ASC deficiency 
on the Chlamydia-induced T–cell cytokine profile. Results revealed a decrease in 
secretions of IL-12, IFN-α, MIP-1β and TNF-α in the ASC -/- BMDC+T cell co–culture, 
while IL-2,-5, and -13 secretions increased compare to the WT BMDC +T cell culture 
co– culture (Figure 12A).  We next examined the antigen presenting function of BMDCs 
in the absence of ASC.  Data showed a significant impairment in the ability of ASC-/- 
BMDCs to induce Ag-specific proliferation of T–cells (p< 0.012) (Figure 12 B).  This 
suggests that ASC deficiency in DCs abrogates their capacity to activate elevated T-cell 







Figure 12: Effect of ASC deficiency on antigen presentation for T-cell activation and proliferation by 
DCs.  A. ASC-/- BMDC T–cell activation was significantly decreased compared to WT BMDCs.  B. 





6.8 Cotransfer of ASC-/- BMDCs promotes Chlamydia infection 
For further support of our hypothesis on the immunoregulatory effects of ASC 
following Chlamydia infection, the course of infection in adoptively transferred mice was 
monitored (Figure 13).  Chlamydia infection within the WT mice mimics the trend that 
we previously observed where there is a gradual steady decrease of chlamydial shedding 
through Day 28 (27).  Figure 13 shows that the IFUs from the group of Chlamydia 
stimulated WT BMDCs transferred into WT mice began to decrease by Day 9 with the 
infection cleared by Day 21, indicating an end to the infection one week earlier than the 
group of unstimulated WT BMDCs transferred into WT mice.   
Here, our results revealed that the mice that received the ASC-/- BMDCs were 
more vulnerable to increased chlamydial shedding.  WT mice that received unstimulated 
ASC-/- BMDCs experienced an immediate increase of chlamydial shedding between Days 
3–9, a gradual shedding decrease between Days 9–21, and by Day 28 there was the 
appearance of the beginning of another chlamydial shedding peak when compared to the 
WT mice course of infection.  The course of infection with the group of Chlamydia 
stimulated ASC-/- BMDCs transferred into WT mice resembled that observed by the 
transferred ASC-/- BMDCs into WT mice group.  Chlamydial shedding from the 
Chlamydia stimulated ASC-/- BMDCs group began with an overall increase from Days 3–
12, followed by a steady decline through Day 28, and ending with an increase in the 
number of IFUs observed when compared to the unstimulated and Chlamydia stimulated 





shedding, while at the same time causes a decrease in the host immune response required 
for infection clearance. 
 
 
Figure 13: Cotransferred Chlamydia primed ASC-/- DCs.  Bone marrow derived ASC-/- DCs 
transferred into WT mice yielded a decrease of chlamydial shedding during the course of infection 
similar to WT. 
 
6.9 ASC deficiency inhibits BMDC CARD12 expression 
The expression of ASC in unstimulated and Chlamydia stimulated WT and ASC-/- 
BMDCs was assessed by immunoblotting (Figure 14A) and showed that ASC expression 





study we show that Chlamydia stimulated ASC-/- BMDCs have increased expression of 
caspase-11, pro–caspase–1 and IL-18 when compared to WT BMDCs (Figure 14B).  We 
also checked the expression of components of ASC-dependent inflammasomes; NLRP3, 
CARD12, AIM2, along with caspase-8. The results indicate no significant changes in 
expression of NLRP3, AIM2, or caspase-8 between WT BMDCs and ASC-/- BMDCs. 











Figure 14: Western blot analysis of Chlamydia stimulated WT and ASC-/- BMDCs protein expression.  
A. ASC deficiency resulted in the loss of CARD12 expression, however, no significant changes were 
observed with the other ASC – dependent inflammasome components NLRP3 or AIM2.  B. Casp – 8 
expression remained similar, while the absence of ASC increased pro–Casp–1, Casp–11, and, IL–18. 
 
6.10 Chlamydia stimulated ASC-/- BMDCs exhibit mitochondrial damage 
Numerous studies have indicated that the mitochondria functions as a regulator of 
NLRP3 inflammasome activation (31, 32), yet little is known about the role of the 
inflammasome on mitochondrial dynamics. Therefore, we investigated the impact of 
ASC on mitochondrial morphology.  The morphology of mitochondria in WT and ASC-/- 
BMDCs in the presence or absence of Chlamydia was evaluated by electron transmission 
microscopy (TEM) (Figure 15). The results showed that the ultrastructure of nearly all 





unstimulated ASC-/- DCs.  However, in stiimulated ASC-/- BMDCs we observed some 
discernible changes in mitochondrial morphology compared to the normal narrow 
pleomorphic cristae in unstimulated and stimulated WTBM DCs and unstimulated ASC-/- 
BMDCs, mitochondria of stimulated ASC-/- DCs were observed to have undergone a 
gradual disruption of the cristae. In some of the abnormal mitochondria, few remnants of 
the cristae were observed. 
It should be noted that we also analyzed several apoptotic protein expressions 
within the BMDCs of both WT and ASC-/-.  The expression levels s of Bcl–2, Bax, 
ANT1/2/3/4, and, Cytochrome C were not detectable from either Chlamydia stimulated 
BMDC group.  These findings indicate that ASC deficiency preserves the mitochondrial 








Figure 15: TEM images of WT and ASC -/- BMDCs pre- and post- Chlamydia stimulation. Deletion of 
ASC leads to morphology changes only within the BMDC mitochondria stimulated with Chlamydia.  
Magnification is 30,000X; scale bar indicates 400nm. 
  
6.11 Effect of ASC on DC immunometabolism 
The damage exhibited by the mitochondria from the Chlamydia stimulated ASC-/- 
BMDC prompted us to examine the glycolytic pathway.  We hypothesized that ASC 
deficiency might cause changes in the DC metabolic pathway. To determine the effect of 
ASC deficiency on immunometabolism in Chlamydia stimulated DCs, we evaluated the 





pyruvate production in ASC-/- BMDCs was markedly reduced compared to WT BMDCs 
in response to Chlamydia stimulation (Figure 16A).  HEK II, ENO-1, and TIM protein 
levels were not affected by the absence of ASC pre- or post-Chlamydia stimulation 
(Figure 16B).  Interestingly, PDHA1 expression was gradually reduced in stimulated 
ASC-/- BMDCs. PDHA1 is encoded by the PDHA1 gene and provides the primary link 
between glycolysis and the tricarboxylic acid (TCA) cycle by catalyzing the irreversible 
conversion of pyruvate into acetyl-CoA, which is utilized for protein acetylation and fatty 
acid synthesis. Those results suggest that ASC deficiency inhibited a needed alternation 
in metabolism of DCs and down–regulated the conversion of pyruvate into acetyl-CoA. 
Both of which are required to meet the increased bioenergetics and biosynthetic demands 
of an activated DC, specifically by funneling metabolites into pathway for lipid and 
protein synthesis. This downregulation in the conversion of pyruvate into acetyl-CoA 







Figure 16: ASC-/- results in a decrease of pyruvate production in Chlamydia stimulated BMDCs.  A. 
Pyruvate concentration post Chlamydia stimulation were significantly reduced within the ASC-/- 
BMDCs (p<0.05).  B. Glycolytic enzymes, HEK II, ENO-1, and TIM protein levels were not affected 
by the absence of ASC pre- or post-Chlamydia stimulation. PDHA1 expression was gradually 









C. trachomatis infections are the most common bacterial STI within the US, 
affecting the mucosal tissues of humans, mammals, and, birds.  A persistent infection 
within the host exerts a cytotoxic effect on the reproductive system, contributing to tubal 
pathology and ending with TFI (29).  Initiation of adaptive immunity is required for 
Chlamydia clearance; however, the recruitment of inflammasomes, activation of 
inflammatory caspases, and, the ensuing inflammatory response is also known to be a 
contributing factor to Chlamydia induced pathology (10).  It has been suggested that host 
inflammatory and anti – microbial immune responses to infection involving cytokines are 
the key determinants of Chlamydia-induced tubal pathology (30).  Therefore, there needs 
to be a way to regulate the delicate balance between a protective anti – microbial and a 
pathologic immune response during Chlamydia infection (27). 
IL–10 is a multifunctional anti–inflammatory cytokine with diverse effects on 
most hemopoietic cell types, including regulation of DC and Th cell growth and 
differentiation (33, 34).  As expected, an increase in the production of IL–10 was 
reported following C. trachomatis infection; however, it should also be noted that a 





 group decided to further investigate the connection of Chlamydia and IL–10 in hopes of 
discovering unknown links between IL–10 and Chlamydia induced pathologies. 
To investigate the role of IL-10 in the protective and immunopathogenic 
responses during chlamydial infection, we tested the hypothesis that IL-10 regulates 
inflammasome activation in DCs exposed to Chlamydia, thereby influencing the APC 
function and the induction of immunity that controls inflammatory tubal pathology and 
infertility. Results of this study suggest that IL-10 deficiency limits tubal damage and 
infertility in Chlamydia infected mice, and it enhances the antigen handling function of 
DCs while suppressing caspase-induced DC apoptosis. The capacity to assemble NLRP3 
inflammasome was also diminished in Chlamydia stimulated IL-10-/- DCs. This study 
describes the regulatory role of IL-10 in DC inflammasome assembly, which might be 
part of the mechanism that forms the basis for the rapid Chlamydia clearance, retention of 
normal tissue architecture and essentially normal fertility rates in Chlamydia infected IL-
10-/- mice (27). 
Of particular interest from our study was the observed 3.5 fold downregulation of 
ASC from IL–10-/- DCs in comparison to WT DCs, which lead to an IL–10 and ASC–
dependent inflammasome linkage.  Taken in to consideration: 1) The innate immune 
response to Chlamydia infections is driven by the activation of inflammatory caspases, 2) 
inflammasome assembly is required for inflammatory caspase activation, and, 3) ASC 
downregulation was associated with decreased chlamydial induced pathology in IL–10-/- 





Chlamydia induced tubal pathologies.  It has previously been reported that a single 
chlamydial infection of the UGT does not result in tubal scarring; however, prolonged 
exposure to Chlamydia due to a chronic persistent infection or frequent reinfection has 
been associated with chronic inflammation associated with TFI (2).  Inflammasome 
activation produces the essential pro – inflammatory cytokines, which in turn recruit an 
influx of immune cells necessary to begin the clearance of C. trachomatis.  Therefore, we 
examined the association between ASC and Chlamydia through an infectivity study 
following an acute infection.  Based on previous data, the expectation was that ASC-/- 
mice course of infection would be similar to the IL–10 studies.  However, the opposite 
was observed.  ASC-/- and WT mice IFU count trend was similar for the first week, but by 
the second week the course of infection for WT mice began to decline as usual.  IFUs 
reported in the ASC-/- mice began to increase until well into the third week, and then only 
experienced a slight decrease, ending with an increased number of IFUs in comparison to 
the WT mice.  Our WT mice infectivity data coincides with that of documented primary 
Chlamydia infections (37).  The course of infection was also evident within the 
histological assessments and fertility study, which focused more on the effects of chronic 
infections.   
Successful fertility relies on intact, functioning, and, secreting cells within the 
UGT.  An Immunological Paradigm for Pathogenesis emerges as a consequence of 
recurrent infections C. trachomatis.  This induced histopathology results in the influx of 





and scarring tissues (2, 8).  Hence, the cells can no longer transport the gamete through 
the UGT (9).  We investigated the immunoregulatory effects of ASC on chronic 
Chlamydia induced histology, pathology, and, fertility.  As expected from our infectivity 
study, due to the longer of incidence at higher IFUs, ASC-/- mice displayed more 
hydrosalpinx, one of the hallmarks of a Chlamydia infection, than the WT mice.  Routine 
H&E staining was able to show a deficiency in ASC does not in fact cause unwarranted 
inflammation prior to infection.  This piece of data was extremely important because it 
allows for a true baseline for all future experiments involving this particular knockout 
model.  Tissue damage within the UGT of ASC-/- mice was more severe in comparison to 
the UGT of WT mice.  A possible explanation of these results involves the difference in 
chlamydiae bacterial load within the two groups.  ASC-/- mice experienced a longer 
duration at higher IFUs.  Such an environment is not only optimal for ascension of the 
bacteria into the UGT, but also provides enough time for binary fission.  As observed in 
the histological data, fertility analysis confirmed that ASC deficient mice were not 
predisposed to fertility issues prior to infection, while at the same time proving to be 
more susceptible to Chlamydia induced infertility.  These findings also warrant the 
question if cellular damage was not so widespread, would ASC-/- show an even greater 
difference to the WT mice within the infectivity study. 
Further analysis into the environment of the infected GT of WT and ASC-/- lead 
us to more interesting results.  Confocal data revealed a decrease in the distribution of 





exhibited cell profile was not.  The population of Macrophages and CD4+ T – cells were 
significantly reduced, but the infected ASC-/- DC population closely matched that of the 
infected WT DC population.  These findings raised the question if ASC deficiency affects 
the ability of DCs to function properly, possibly with antigen presentation.  An UGT T–
cell co–culture revealed that infected ASC-/- DCs lacked the ability to present antigen and 
overall T–cell proliferation decreased.  The co–culture was followed by cytokine and 
immunoblotting analysis, with both confirming that ASC deficiency causes a loss of the 
protective immunity seen within WT mice.  Because the inflammasome is important in 
activating the innate immunity and the ensuing adaptive immunity response (9, 38), 
signaling for these downstream effects relies on the capability of APCs to function 
properly and in rapid succession for clearance.  DCs are important when it comes to 
antigen presentation; they are the link between the innate and adaptive immune systems 
post C. trachomatis infection (38).  Here we have shown that there exist a disconnect 
with switching between the immunity systems, and it appears that the DC’s ability to 
function properly is at the root of the issues. 
In an effort to better understand how the absence of ASC affects the ability of 
DC’s to not only function properly, but also to mature in response to a pathogen, we 
started to focus on the effects of Chlamydia stimulation on BMDCs.  During preliminary 
Flow Cytometry studies, we began to notice that the expression of ASC deficient BMDC 
surface markers was in opposition to that of WT BMDC surface marker expressions.  





molecules such as CD40, CD80 and CD86, which are crucial for effective T-cell 
activation (38–40).  But, in this study we observed a downregulation in both CD40 and 
MHC II expression, and an upregulation in CD103 expression.  Emerging data have 
begun to identify new DC population subsets, similar to that of T–cells and macrophages. 
The classical designations of these subsets fall into two categories known either as 
immunogenic or tolerant (41). Everts and colleagues go on to postulate that the 
immunogenic DCs display an increased glycolytic and MHC expression, and initiate 
inflammatory T–cell responses (42).  Subsequently, tolerogenic DC subsets are 
characteristically resistant to maturation, immune modulatory factors, and have low 
glycolytic levels, which are strongly correlated with an increase in regulatory T–cell 
responses (43–46).  Likewise, our co–culture and adoptive transfer assays resulted in a 
decrease in the ability of ASC-/- BMDCs to effectively present and activate T–cells. 
It is becoming increasingly clear that DC activation coincides with cellular 
metabolism that is tailored towards the bioenergetic and biosynthetic needs of DCs (47). 
Notable changes include enhanced glycolysis, the accumulation of succinate and the 
biosynthesis of fatty acids from citrate to support lipid biosynthesis, facilitating the 
expansion of ER and Golgi apparatus and increasing the biosynthetic capacity that is 
essential for the maturation and activation of DCs (48–51).  Oxidative phosphorylation 
(OXPHOS) and fatty acid oxidation (FAO) are the main energy sources of DCs in the 
immature state, and upon LPS stimulation, DCs switch from OXPHOS to anabolic 





has been established that mitochondrial changes, such as a decrease in mitochondrial 
transmembrane potential (ΔΨm) along with the release of cytochrome C regulates 
NLRP3 inflammasome activation (54).  Here we have shown that in the absence of ASC, 
Chlamydia stimulated BDMCs exhibit decreased pyruvate production and are unable to 
undergo the metabolic alterations due to the cristae obliteration.  Yet, through our 
immunoblotting analysis, we have shown that ASC deficiency does not result in the 
detection of apoptotic proteins, have an effect on the expression of glycolytic proteins or 
the ASC–dependent inflammasome components NLRP3 or AIM2.  There was, however, 
a decrease in the expression of PDHA1 and the other ASC–dependent inflammasome 
component CADR12.  Interestingly, the NBS domain of NLRC4 is a pocket with 
specificity for ATP and dATP and a requirement for CARD12 oligomerization, 
association, and, activation of caspase-1 (55).  ASC induced mitochondrial disruption 
appears to impair the generation of ATP, which may abolish ATP/dATP binding and 
markedly reduce CARD12 self-association and interaction with pro–caspase–1.  Our data 
also suggest that the mitochondria cristae damage associated with the loss of ASC, may 
in turn increase reactive oxygen species (ROS) production, and subsequently enhance c-
Jun N-terminal kinase (JNK) signaling, which would result in the observed increased 








Infectious agents can damage biological functions of the female reproductive tract 
with devastating consequences. Among the most common microorganisms involved in 
STIs and interfering with female fertility is C. trachomatis. The impairment from this 
pathogen can be viewed within the cervix, fallopian tubes and tubal luminal architecture 
in infected women (2, 8-9, 23).  Within this study, we have been able to provide more 
evidence which supports the claims that ASC is emerging as a key mediator in both 
protection and inflammation.  Additionally, we have suggested a very plausible 
connection between the role of ASC, GT pathology, infertility, and, Chlamydia 
infections.  Our initial data indicates the important immuno–protective role of ASC that 
may be required for mucosal immunity against chronic Chlamydia GT infection and 
Chlamydia induced tubal damage and TFI in the mouse model.  However, continued 
investigations into the mechanisms of chronic Chlamydia induced cellular and tissue 
damage are required in order to develop further our understanding on the pathogenesis of 
GT disease caused by this specific bacterium, and to direct research into effective ways to 
control C. trachomatis infection, including the possibility of assigning ASC as a potential 





propose that ASC is an important molecule in the reprogramming of DC metabolism and 
in keeping mitochondrial structure intact after stimulation with Chlamydia (57–60).  In 
line with that, infected ASC-/- DCs are unable to rapidly activate and effectively present 
antigen to T–cells, which is crucial for controlling Chlamydia clearance and preventing 
future complications (48, 55, 61, 62). This study was able to establish a baseline for 
determining the effect of the inflammasome on DC immunometabolism in Chlamydia 
immunity.  However, we are only beginning to understand the extent to which ASC–
metabolism is interlinked with the functional properties of DCs. There are still many 
questions which will rely on future investigations. It is of the upmost importance to fully 
understand the role of ASC in DC immunometabolism, which not only will improve our 
fundamental understanding of the biology of DCs, but will also be important in the 
development of metabolism–based approaches to improve the efficacy of DC–based 
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